#Continuous Renal Replacement Therapy Market size

[industrynewsupdates]

Continuous Renal Replacement Therapy Market Scenario, Size, Outlook and Forecast Report, 2030

The global Continuous Renal Replacement Therapy market was valued at USD 1,356.7 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. Several factors are driving this growth, including the increasing incidence of acute kidney injury (AKI), the rising number of sepsis cases, an expansion in the number of hospitals and urgent care centers, higher hospital admission rates, and consistent product innovations by leading market players. According to the American Kidney Fund, 37 million U.S. citizens are living with kidney disease, and 807,000 people in the U.S. are diagnosed with kidney failure. These statistics highlight the growing need for CRRT treatments, which are used to manage kidney failure and other kidney-related conditions.

The growing prevalence of kidney disease, especially in the aging population, is a major driver of demand for CRRT. Kidney diseases, such as Chronic Kidney Disease (CKD) and AKI, are leading causes of mortality worldwide. As these conditions increase in frequency, the need for effective renal replacement therapies, such as CRRT, grows. There has been significant progress in the technology used in CRRT devices, which has improved both clinical outcomes and the overall efficiency of treatment. Modern CRRT systems now feature automated data collection and standardized language protocols, enabling cross-institutional data comparisons. These advancements allow healthcare providers to better tailor treatments to individual patient needs, thereby improving patient outcomes and boosting the adoption of CRRT technologies. 

With advanced CRRT devices, clinicians are better able to monitor and manage treatment parameters, which helps to improve patient care. The integration of real-time data, automation, and precise delivery of therapy ensures that patients receive the most appropriate care, ultimately leading to better recovery rates and reduced mortality. As a result, hospitals and healthcare providers are increasingly adopting these advanced CRRT machines, which is expected to drive the market further. The rise in hospital admissions due to kidney-related illnesses, as well as the rapid expansion of urgent care centers, is also contributing to the increasing demand for CRRT devices. The healthcare industry's growing infrastructure and emphasis on critical care units and intensive care units (ICUs) is making CRRT more accessible to patients worldwide.

Gather more insights about the market drivers, restrains and growth of the Continuous Renal Replacement Therapy Market 

Regional Insights:

North America

In 2022, North America held the largest revenue share of 36.5% of the global CRRT market. Several factors contribute to this dominance:

• Aging Population: The aging population in North America, especially in the U.S., is a key factor in the rising demand for CRRT. As people age, the incidence of kidney diseases such as Chronic Kidney Disease (CKD) and AKI increases, creating a higher need for renal replacement therapies.

• Prevalence of Kidney Disorders: According to the U.S. Department of Health and Human Services, over 1 in 7 U.S. adults is estimated to have CKD, and the incidence of kidney failure continues to rise. This widespread prevalence of kidney disease is a significant driver for the adoption of CRRT therapies in hospitals and healthcare systems.

• Lifestyle Factors: The growing adoption of sedentary lifestyles and unhealthy dietary habits in North America has led to an increase in lifestyle-related diseases such as hypertension, diabetes, and kidney dysfunction, all of which contribute to the rising demand for CRRT.

• Technological Advancements and Healthcare Infrastructure: The high adoption of cutting-edge healthcare technologies, coupled with an extensive healthcare infrastructure, makes North America a leader in the CRRT market. Hospitals and urgent care centers are increasingly equipped with advanced CRRT machines, further boosting market growth.

Asia Pacific 

The Asia Pacific region is projected to grow at the fastest CAGR of 9.8% over the forecast period. Several factors contribute to this rapid growth:

• Increasing Prevalence of Chronic Diseases: The rising incidence of diabetes, CKD, and hypertension in countries like China, India, and Japan is driving the demand for CRRT solutions. These chronic conditions are major risk factors for kidney failure, creating a pressing need for effective renal replacement therapies.

• Growing Healthcare Expenditure: The rising investment in healthcare infrastructure and increased healthcare spending in Asia Pacific countries are also contributing to market growth. Governments in the region are increasingly focusing on improving healthcare access and quality, especially in critical care and nephrology.

• Regulatory Support: In China, the government has introduced favorable policies such as the reduction in Value Added Tax (VAT) for medical manufacturing companies, which has encouraged the growth of the medical devices industry. These policies have made China an attractive market for medical device manufacturers, including those involved in CRRT solutions.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

• The global topical scar treatment market size was estimated at USD 1.69 billion in 2024 and is expected to grow at a CAGR of 11.9% from 2025 to 2030.

• The global demineralized bone matrix market size was estimated at USD 1.24 billion in 2024 and is projected to grow at a CAGR of 5.9% from 2025 to 2030.

Key Companies & Market Share Insights:

As demand for CRRT products rises, global manufacturers are accelerating production while also focusing on cost-effective solutions. Some notable companies and their activities in the CRRT market include:

• Nipro Corporation: In March 2022, Nipro, a leader in renal care products, launched the SURDIAL DX system. This futuristic hemodialysis system is designed to optimize dialysis treatment, making it more efficient and patient-friendly. By improving treatment quality, Nipro aims to strengthen its position in the CRRT market.

• Baxter International: In April 2022, Baxter International received FDA 510(k) clearance for its ST set, a product used in continuous renal replacement therapy. The ST set is pre-connected, uses a semipermeable membrane to purify blood, and is compatible with PrisMax or Prismaflex systems. This new clearance underscores Baxter's commitment to innovation and expanding its CRRT product line.

• Fresenius Medical Care: In June 2021, Fresenius Medical Care inaugurated a training center in Korea, aimed at supporting education for healthcare professionals in areas such as critical care, renal care, and treatment strategies. By focusing on training healthcare providers, Fresenius seeks to improve the quality of care and patient outcomes, thus driving the demand for CRRT therapies.

Key Continuous Renal Replacement Therapy Companies:

• B. Braun Melsungen AG

• Baxter International, Inc.

• Fresenius Medical Care AG & Co. KGaA

• Asahi Kasei Corporation

• NIPRO Corporation

• Toray Medical Co., Ltd

• NxStage Medical, Inc.

• Medtronic PLC

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

[research-89]

https://cynochat.com/read-blog/180364_continuous-renal-replacement-therapy-market-analysis-size-share-and-forecast-203.html

[medi-techinsights]

Global Continuous Renal Replacement Therapy Market is poised to grow at a CAGR of 7 to 9% by 2027

Continuous Renal Replacement Therapy (CRRT) is a slow and gentle form of dialysis which removes excessive fluids and waste products from the blood in a continuous manner, similar to the manner the kidneys functions in healthy people.

Adoption of Continuous Renal Replacement Therapy for the Treatment of Sick Patients with Acute Kidney Injury (AKI) Disorder

AKI is a global disorder and is very common among sick patients. It is projected that approximately 13.3 million people globally are affected by AKI yearly, ~85% of whom live in developing regions. The major objectives of CRRT for sick patients suffering from AKI include maintaining fluid, electrolyte, acid-base, and solute balance, supporting renal recovery, and allowing other supportive interventions to proceed without any further complications.

Major Benefits Associated with CRRT Fuels the Growth of the Continuous Renal Replacement Therapy Market

Hemodynamic instability is common among sick patients with AKI receiving RRT. CRRT may have a better hemodynamic profile as compared to other intermittent therapies, including intermittent hemodialysis (IHD) and sustained low-efficiency dialysis. Among the major benefits offered by CRRT, comparative to other RRT, is the prevention of changes in intracerebral water. CRRT is considered much safer than IHD in patients at risk of cerebral edema.

Increasing Awareness on Kidney Health & Prevention Program Triggers the Growth of the CRRT Market

Presently, a large number of kidney health & prevention programs are run by organizations such as National Kidney Foundation (NKF), The National Kidney Disease Education Program (NKDEP), and local governments across the globe to raise awareness on the evidence-based interventions to enhance understanding, detection, and management of various kidney diseases.

Impact of Covid-19 Pandemic on the Continuous Renal Replacement Therapy Market

Globally, all the healthcare systems have been impacted by the COVID-19 pandemic. During covid-19, approximately 15% to 30% of patients affected with COVID-19 virus admitted to the ICU were showing signs of kidney failure and they required CRRT. In such scenarios, CRRT acted as a life-sustaining and as a life-saving therapy.

Upcoming Market Challenges: Continuous Renal Replacement Therapy Market

The higher costs associated with the CRRT procedures and the risks & complications associated with CRRT such as catheter-related complications, blood loss, infection or access failure, fluctuations in salt balance, hemodialysis-related complications, coagulopathy, and venous thrombosis are likely to impact the growth of the CRRT market in the coming years.

North America Accounts for the Larger Market Share in the CRRT Market

From a geographical outlook, North America accounts for the larger market share in the global continuous renal replacement therapy market. This can be mainly attributed to the growing cases of AKI, rapid innovations in continuous renal replacement therapy products, and a surge in the number of diabetic patients in North America.

Competitive Landscape Analysis: CRRT Market

Some of the leading and promising players operating in the global continuous renal replacement therapy market are Baxter, B. Braun, Fresenius Medical Care AG, Medtronic, Nipro Corporation, etc.

Get Detailed Insights on Continuous Renal Replacement Therapy Market @ https://meditechinsights.com/continuous-renal-replacement-therapy-market/

[roshankumar7904800]

Brazil Renal Dialysis Equipment Market

Brazilian Renal Dialysis Equipment Market Size, Share, Trends: Fresenius Medical Care Leads

Move Toward Dialysis Treatments Performed at Home

Market Overview:

The Brazilian renal dialysis equipment market is predicted to grow at a 5.8% CAGR, from USD 760 million in 2022 to USD 1.2 billion by 2031. The rising frequency of chronic kidney diseases, the growing diabetic and geriatric population, and increased awareness of renal health will all contribute to significant market growth. Technological advancements in dialysis equipment, as well as expanding healthcare infrastructure, are also boosting market expansion. However, tight reimbursement policies and high treatment costs may limit expansion.

DOWNLOAD FREE SAMPLE

Market Trends:

Particularly peritoneal dialysis and home hemodialysis, the Brazilian market is showing an increasing inclination for home-based dialysis treatments. Lower healthcare expenses, fewer hospital visits, and better patient comfort all help to explain this trend. As patients want to reduce exposure hazards connected with in-center treatments, the COVID-19 epidemic has sped this change even further. Manufacturers of equipment are reacting by creating smaller, more user-friendly tools fit for household usage. Home dialysis systems now include telemedicine and remote monitoring technology, which let doctors carefully track patients' development and change therapy programs as necessary.

Market Segmentation:

The hemodialysis equipment segment is likely to maintain its significant share in the Brazil renal dialysis equipment market over the projection period. Hemodialysis machines, dialyzers, bloodstream systems, and other pertinent accessories are part of this section. With about 90% of all dialysis treatments in Brazil going toward hemodialysis, it is still the most often utilized renal replacement treatment available there. The segment's expansion is driven by elements like the huge patient pool, rising end-stage renal disease prevalence, and continuous hemodialysis equipment technical innovation.

Market Key Players:

The Brazilian renal dialysis equipment market is highly competitive, with major players focusing on product innovation, strategic alliances, and extending their distribution networks. Key companies such as Fresenius Medical Care, Baxter International Inc., B. Braun Melsungen AG, Nipro Medical Corporation Brazil, Diaverum Brasil, DaVita Inc., Medtronic plc, Asahi Kasei Corporation, Nikkiso Co., Ltd., and Toray Medical Co., Ltd. dominate the market.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[global-research-report]

Revolutionizing Critical Care: The Role of CRRT in Modern Renal Treatment

Continuous Renal Replacement Therapy Industry Overview

The global continuous renal replacement therapy market size is anticipated to reach USD 2,603.8 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2023 to 2030. The primary driving factors for market growth are increasing prevalence of congestive heart failure and acute renal failure. The COVID-19 is expected to have a positive impact on market due to increasing prevalence of acute kidney injury. According to a WHO, acute kidney injury, a potentially life-threatening condition in which the kidneys cease working and uremic and fluid toxins build up in the body, is one of the many COVID-19 side effects. As a result, as the COVID-19 outbreak expands, demand for CRRT will continue to climb.

Gather more insights about the market drivers, restrains and growth of the Continuous Renal Replacement Therapy Market

Over the forecast period, technological advancements are expected to be a crucial driver in the growth of the market. For example, in August 2020, Baxter International Inc., a global leader in acute care, announced that Regiocit, the company's replacement solution containing citrate for extracorporeal circuit regional citrate anticoagulation, has acquired an Emergency Use Authorization (EUA) from the U.S Food and Drug Administration (FDA). Regiocit is exclusively approved for use as a replacement solution in adult patients receiving Continuous Renal Replacement Therapy (CRRT) and who require regional citrate anticoagulation during the COVID-19 pandemic, according to the EUA.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global wearable artificial organs market size was estimated at USD 11.13 billion in 2024 and is projected to grow at a CAGR of 17.2% from 2025 to 2030. 

The global 3D medical imaging devices market size was estimated at USD 12.74 billion in 2024 and is expected to expand at a CAGR of 8.11% from 2025 to 2030.

Continuous Renal Replacement Therapy Market Segmentation

Grand View Research has segmented the global continuous renal replacement therapy market on the basis of product, modality, and region:

Continuous Renal Replacement Therapy Product Outlook (Revenue, USD Million, 2018 - 2030)

System

Consumables

Continuous Renal Replacement Therapy Modality Outlook (Revenue, USD Million, 2018 - 2030)

Slow Continuous Ultra-Filtration (SCUF)

Continuous Venovenous Hemofiltration (CVVH)

Continuous Venovenous Hemodialysis (CVVHD)

Continuous Venovenous Hemodiafiltration (CVVHDF)

Continuous Renal Replacement Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Norway

Denmark

Asia Pacific

China

Japan

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

Key Companies profiled:

Braun Melsungen AG

Baxter International, Inc.

Fresenius Medical Care AG & Co. KGaA

Asahi Kasei Corporation

NIPRO Corporation

Toray Medical Co., Ltd

NxStage Medical, Inc.

Medtronic PLC

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

[marketanalysisdata]

Continuous Renal Replacement Therapy Market 2030 - In-Depth Analysis on Size, Trends & Prominent Key Players

The global continuous renal replacement therapy market was valued at USD 1,356.7 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. Factors contributing to this growth include the rising incidence of acute kidney injury (AKI), an increase in sepsis cases, the rapid expansion of hospitals and urgent care centers, growing hospital admission rates, and continuous product innovations by leading companies. The American Kidney Fund reports that 37 million Americans are living with kidney disease, and around 807,000 individuals in the U.S. have been diagnosed with kidney failure.

Demand for advanced CRRT devices is a major driver in the market due to improved patient outcomes. The latest CRRT technology allows for comprehensive analysis and response to technical data, significantly enhancing quality assurance. These technological advancements have led to a more precise evaluation of prescription and delivery patterns, positively impacting clinical results. Modern CRRT devices enable automated data collection and use standardized language, facilitating comparisons across institutions. Leading manufacturers have introduced sophisticated CRRT machines incorporating these capabilities, which is expected to further accelerate market growth.

Gather more insights about the market drivers, restrains and growth of the Continuous Renal Replacement Therapy Market

Additionally, the development of specialized CRRT products for pediatric patients is anticipated to boost the market. Traditionally, pediatric CRRT cases have relied on systems designed for adults, which are not specifically licensed for pediatric use, posing potential clinical challenges, especially for neonates. To address these issues, several manufacturers now provide a range of renal care solutions to improve access, outcomes, and quality of life for pediatric patients with severe renal conditions, driving market expansion globally.

According to the American Hospital Association, in 2023, the U.S. had 5,157 community hospitals, 206 federal government hospitals, and 107 other hospitals. An increase in hospital admissions for AKI and a growing elderly population are fueling the demand for CRRT systems. Moreover, the Centers for Disease Control and Prevention (CDC) reported that, as of 2021, approximately 786,000 Americans had end-stage renal disease (ESRD), also known as end-stage kidney disease (ESKD), with 71% on dialysis and 29% with a kidney transplant. In 2020, there were around 7,500 dialysis clinics in the U.S., underscoring the need for CRRT solutions.

Modality Segmentation Insights:

The CRRT market can be segmented into different modalities: slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). In 2022, the CVVH segment led the market with a revenue share of 31.6%, driven by the high prevalence of fluid overload among AKI patients in critical care settings. Fluid overload, often seen in congestive heart failure cases, significantly impacts dialysis patients. According to an article in Elsevier, congestive heart failure accounted for roughly 5% of all-cause mortality among dialysis patients, a condition closely related to fluid overload. This association is expected to increase demand for CVVH treatment.

The CVVHDF segment is anticipated to grow at the fastest CAGR of 9.2% over the forecast period. CVVHDF, which utilizes a highly effective hemodiafilter, enables the combined removal of fluid and solutes, merging both hemodialysis and hemofiltration techniques. This treatment involves comprehensive fluid and solute clearance from the blood and has become the most commonly used CRRT modality for AKI in various countries. CVVH was the primary CRRT modality until CVVHDF was introduced in 2008, which quickly became the dominant CRRT approach. CVVHDF’s association with higher survival rates relative to other CRRT options is expected to contribute to its rapid market growth in the coming years.

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

[latestmarketresearchnews]

Continuous Renal Replacement Therapy Market Report: Size, Share & Forecast till 2030

The global market for continuous renal replacement therapy (CRRT) was valued at USD 1,356.7 million in 2022, with an expected compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. This growth is driven by several key factors, including the rising incidence of acute kidney injury (AKI), an increasing rate of sepsis, a rapid expansion of hospitals and urgent care centers, and a growing number of hospital admissions. Additionally, constant product launches and innovations from major players in the CRRT space are boosting demand for these treatments. According to the American Kidney Fund, 37 million people in the United States live with kidney disease, and approximately 807,000 are diagnosed with kidney failure, underscoring the critical need for CRRT.

Before the COVID-19 pandemic, around 23,105 patients with AKI required CRRT annually. The pandemic, however, significantly increased the demand for CRRT, as COVID-19-associated AKI reached nearly 4 million cases per year. Among COVID-19 patients, the need for CRRT surged to 4.9%, five times higher than historical rates of 0.9%. In regions across North America, the number of people utilizing CRRT increased by an unprecedented 370% above typical levels. This spike in demand prompted major CRRT providers like Fresenius Medical Care North America to respond rapidly. For instance, in May 2020, Fresenius, through its Renal Therapies Group, released the first batch of multiBic dialysate solutions to U.S. hospitals under FDA emergency use authorization. These solutions were critical in providing CRRT to COVID-19 patients with acute kidney failure.

Gather more insights about the market drivers, restrains and growth of the Continuous Renal Replacement Therapy Market

Product Segmentation Insights:

The CRRT market is segmented into systems and consumables. In 2022, the consumables segment held the largest market share, accounting for 60.6% of total revenue, and is anticipated to grow at the fastest CAGR of 9.1% over the forecast period. Consumables, including charcoal filters, hemofilters, fluids, and other essential components, are widely used in CRRT. Hemofilters, or artificial kidneys, are central to this segment; they use a hollow fiber membrane that determines solute and fluid removal rates. Major players like Baxter and Fresenius offer a broad range of consumables across multiple CRRT modalities, making these products a consistent choice for renal therapy. While consumables are relatively low-cost, they are frequently repurchased due to their essential role in each CRRT session.

During the COVID-19 surge, Baxter International Inc. reported a fivefold increase in demand for various acute dialysis products due to the rise in patients requiring CRRT. In response, Baxter worked with global partners and government entities to address supply issues and increase the availability of consumables like fluids, helping to meet the extraordinary demand in both Europe and the U.S.

The systems segment is expected to grow at a moderate CAGR of 7.8% over the forecast period. CRRT systems are advanced machines designed to provide renal support through blood and fluid pumps, a user-friendly interface, scales, and integrated safety features. Technological advancements in CRRT systems are enhancing treatment precision and reliability. Innovations include high-volume permeability for better fluid control and integration with Electronic Medical Record (EMR) systems, which is likely to boost this segment's growth. Leading manufacturers are developing more sophisticated CRRT devices that ensure safety and efficiency throughout procedures. For example, in May 2021, Baxter International launched the PrisMax 2, an updated version of its next-generation CRRT platform. The PrisMax 2 is tailored to the specific needs of Intensive Care Units (ICUs), facilitating organ support and CRRT while offering simplified interfaces for easy operation.

The continuous innovations and improvements in CRRT systems and consumables underscore the market's commitment to addressing the growing demand for renal replacement therapies, driven largely by the prevalence of chronic and acute kidney conditions and the substantial impact of the COVID-19 pandemic.

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Continuous Renal Replacement Therapy Market Size, Share | Research Report 2030

The global market for continuous renal replacement therapy (CRRT) was valued at USD 1,356.7 million in 2022, with an expected compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. This growth is driven by several key factors, including the rising incidence of acute kidney injury (AKI), an increasing rate of sepsis, a rapid expansion of hospitals and urgent care centers, and a growing number of hospital admissions. Additionally, constant product launches and innovations from major players in the CRRT space are boosting demand for these treatments. According to the American Kidney Fund, 37 million people in the United States live with kidney disease, and approximately 807,000 are diagnosed with kidney failure, underscoring the critical need for CRRT.

Before the COVID-19 pandemic, around 23,105 patients with AKI required CRRT annually. The pandemic, however, significantly increased the demand for CRRT, as COVID-19-associated AKI reached nearly 4 million cases per year. Among COVID-19 patients, the need for CRRT surged to 4.9%, five times higher than historical rates of 0.9%. In regions across North America, the number of people utilizing CRRT increased by an unprecedented 370% above typical levels. This spike in demand prompted major CRRT providers like Fresenius Medical Care North America to respond rapidly. For instance, in May 2020, Fresenius, through its Renal Therapies Group, released the first batch of multiBic dialysate solutions to U.S. hospitals under FDA emergency use authorization. These solutions were critical in providing CRRT to COVID-19 patients with acute kidney failure.

Gather more insights about the market drivers, restrains and growth of the Continuous Renal Replacement Therapy Market

Product Segmentation Insights:

The CRRT market is segmented into systems and consumables. In 2022, the consumables segment held the largest market share, accounting for 60.6% of total revenue, and is anticipated to grow at the fastest CAGR of 9.1% over the forecast period. Consumables, including charcoal filters, hemofilters, fluids, and other essential components, are widely used in CRRT. Hemofilters, or artificial kidneys, are central to this segment; they use a hollow fiber membrane that determines solute and fluid removal rates. Major players like Baxter and Fresenius offer a broad range of consumables across multiple CRRT modalities, making these products a consistent choice for renal therapy. While consumables are relatively low-cost, they are frequently repurchased due to their essential role in each CRRT session.

During the COVID-19 surge, Baxter International Inc. reported a fivefold increase in demand for various acute dialysis products due to the rise in patients requiring CRRT. In response, Baxter worked with global partners and government entities to address supply issues and increase the availability of consumables like fluids, helping to meet the extraordinary demand in both Europe and the U.S.

The systems segment is expected to grow at a moderate CAGR of 7.8% over the forecast period. CRRT systems are advanced machines designed to provide renal support through blood and fluid pumps, a user-friendly interface, scales, and integrated safety features. Technological advancements in CRRT systems are enhancing treatment precision and reliability. Innovations include high-volume permeability for better fluid control and integration with Electronic Medical Record (EMR) systems, which is likely to boost this segment's growth. Leading manufacturers are developing more sophisticated CRRT devices that ensure safety and efficiency throughout procedures. For example, in May 2021, Baxter International launched the PrisMax 2, an updated version of its next-generation CRRT platform. The PrisMax 2 is tailored to the specific needs of Intensive Care Units (ICUs), facilitating organ support and CRRT while offering simplified interfaces for easy operation.

The continuous innovations and improvements in CRRT systems and consumables underscore the market's commitment to addressing the growing demand for renal replacement therapies, driven largely by the prevalence of chronic and acute kidney conditions and the substantial impact of the COVID-19 pandemic.

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Continuous Renal Replacement Therapy Market Segmentation and Competitive Analysis Report, 2030

The global continuous renal replacement therapy market size was valued at USD 1,356.7 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030. 

Rising incidence of acute kidney injury (AKI), increasing incidence of sepsis, rapid increase in the volume of hospitals and urgent care centers, growing hospital admissions rate, and constant product launches by prominent market players are a few factors driving the demand for CRRT, thereby propelling the market growth. According to the American Kidney Fund, 37 million U.S. citizens are living with kidney disease and 807,000 people in the U.S. are diagnosed with kidney failure.

In the pre-COVID-19 era, the burden of COVID-19-associated AKI climbed to almost 4 million cases per year. CRRT was utilized to treat roughly 23,105 AKI patients per year prior to COVID-19. The need for CRRT appeared to be 5 times higher in COVID-19 patients, i.e., 4.9 percent, than in historical populations (0.9 percent). In community cohort datasets, 5%–15% of people hospitalized with COVID-19 needed dialysis. Moreover, in some North America regions, the number of people utilizing CRRT jumped by 370 percent over normal levels due to which the demand for the product increased during the pandemic. For instance, Fresenius Medical Care North America's Renal Therapies Group (FMCNA) released the first batch of multiBic dialysate solutions to U.S. hospitals in May 2020, according to an FDA emergency use authorization. These medicines were intended to provide CRRT to COVID-19-related individuals with acute renal failure.

Gather more insights about the market drivers, restrains and growth of the Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy Market Report Highlights

• By product, the consumables segment held the largest revenue share of 60.6% in 2022. Although these products are low-priced, it is used repeatedly purchased; hence the market for consumables is the largest as compared to other segments

• Based on the modality, the Continuous Veno-venous Hemofiltration (CVVH) segment held the largest revenue share of 31.6% in 2022. Fluid overload situations, which are common in acute kidney injury patients in critical care units, are expected to increase, boosting the CVVH market's growth

• Asia Pacific was the fastest growing market for continuous renal replacement therapy with a growth rate of 9.8%. Various factors are responsible for the region growth such as technological advancement, growing healthcare infrastructure development as well as and presence of such a huge patient base in this region

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global sentinel node biopsy market size was estimated at USD 717.8 million in 2023 and is projected to grow at a CAGR of 7.0% from 2024 to 2030.

• The global market for endoscopy operative devices reached a value of USD 10.34 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. 

Continuous Renal Replacement Therapy Market Segmentation

Grand View Research has segmented the global continuous renal replacement therapy market on the basis of product, modality, and region:

Continuous Renal Replacement Therapy Product Outlook (Revenue, USD Million, 2018 - 2030)

• System

• Consumables

Continuous Renal Replacement Therapy Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Slow Continuous Ultra-Filtration (SCUF)

• Continuous Venovenous Hemofiltration (CVVH)

• Continuous Venovenous Hemodialysis (CVVHD)

• Continuous Venovenous Hemodiafiltration (CVVHDF)

Continuous Renal Replacement Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o Saudi Arabia

o South Africa

o UAE

o Kuwait

Order a free sample PDF of the Continuous Renal Replacement Therapy Market Intelligence Study, published by Grand View Research.

[alicetleibowitz]

Continuous Renal Replacement Therapy is revolutionizing kidney care worldwide. Discover how this innovative technology is improving patient outcomes and shaping the future of renal treatment.

[datavoyage123]

https://www.verifiedmarketreports.com/pt/product/global-continuous-renal-replacement-therapy-crrt-market-size-and-forecast-to-2025/